ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma
Clinical trial NCT00140660 · TERMINATED
Trial details
- NCT number
- NCT00140660
- Sponsor
- Lymphoma Study Association
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Primary completion
- 2008-07-01
- Enrollment
- 223
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.